Cannabis Report
Home > Boards > US Listed > Biotechs >

Adamas Pharmaceutical Inc. (ADMS)

ADMS RSS Feed 		Add ADMS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/24/2018 3:12:56 PM - Followers: 10 - Board type: Free - Posts Today: 0

Adamas Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is developing its lead wholly owned product candidate, ADS-5102, for a complication of Parkinson's disease known as levodopa induced dyskinesia (LID), and as a treatment for chronic behavioral symptoms associated with traumatic brain injury (TBI). Its portfolio includes product candidates, MDX-8704, being co-developed with Forest Laboratories, Inc. (Forest), for the treatment of moderate to severe dementia associated with Alzheimer's disease, and Namenda XR, which Forest developed and is marketing in the United States under a license from the Company. The Company has completed Phase II/III clinical trial of ADS-5102. ADS-5102 is designed to address many of the limitations of immediate-release amantadine.
Cannabis Report
ADMS
Current Price
Volume:
Bid Ask Day's Range
ADMS Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ADMS News: Statement of Changes in Beneficial Ownership (4) 06/22/2018 04:51:52 PM
ADMS News: Statement of Changes in Beneficial Ownership (4) 06/22/2018 04:49:36 PM
ADMS News: Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throu... 06/22/2018 09:12:56 AM
ADMS News: Adamas Announces New Employment Inducement Grant 06/08/2018 05:55:00 PM
ADMS News: Statement of Changes in Beneficial Ownership (4) 06/07/2018 05:16:05 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#78   Toying with a run into the close. Staypositive1 04/24/18 03:12:56 PM
#77   Getting ready for a run here. Staypositive1 04/24/18 02:02:38 PM
#76   How may this affect ADMS? https://finance.yahoo.com/news/acorda-files-parkinson RainyDayWriter 03/31/18 04:06:42 PM
#75   Benefits of Gocovri in Parkinson's patients: http://crweworld.com/article/news RainyDayWriter 03/20/18 06:33:10 PM
#74   Looks like a long waiting game. Staypositive1 03/01/18 10:14:14 AM
#73   How much do u like HGMT. Hearing Staypositive1 02/12/18 05:24:54 PM
#72   Hells yea Dragonfly79 02/08/18 01:46:13 PM
#71   Looking good here compared to the rest of Staypositive1 02/08/18 01:45:32 PM
#70   Very quickly. Staypositive1 01/30/18 01:54:52 PM
#69   I’m thinking soon. They just raised 85 Dragonfly79 01/29/18 11:37:17 PM
#68   Should see $55 next week. Staypositive1 01/22/18 02:40:42 PM
#67   huronreport.com/adamas-pharmaceuticals-call-adms-holding-increased-by-pura-vida- Staypositive1 12/29/17 08:29:36 AM
#66   https://stocknewstimes.com/2017/12/28/adamas-pharmaceuticals-adms-given-a-55-00- Staypositive1 12/29/17 08:29:14 AM
#65   www.smarteranalyst.com/2017/12/14/analyst-bets-ma-opportunities-drive-big-upside Staypositive1 12/15/17 09:17:22 AM
#64   This keeps getting better Staypositive1 11/30/17 02:51:04 PM
#63   Yes Sir ;) pbor 11/22/17 07:57:05 PM
#62   By end of the day friday. Staypositive1 11/22/17 01:25:00 PM
#61   36 by tomorrow? pbor 11/22/17 01:07:45 PM
#60   My bad, it was $28.5k pbor 11/22/17 12:55:52 PM
#59   Where did the 28k com from again. JustLooking162636 11/22/17 12:45:20 PM
#58   Got it. Thanks pbor 11/22/17 12:07:54 PM
#57   First of all this company doesn't technically have JustLooking162636 11/22/17 11:55:03 AM
#56   It's clear this is going up. Their expensive pbor 11/22/17 11:49:38 AM
#55   I gotcha...sorry about that! Staypositive1 11/22/17 11:38:02 AM
#54   Idk why question marks came out those where JustLooking162636 11/22/17 11:10:58 AM
#53   Bigger than that! Staypositive1 11/22/17 11:08:55 AM
#52   Short squeeze ??????????? JustLooking162636 11/22/17 10:53:24 AM
#51   I think we will find out even bigger Staypositive1 11/21/17 09:13:04 PM
#50   Agree. I doubled my position yesterday. Was telling pbor 11/21/17 06:01:25 PM
#49   $70+ coming Staypositive1 11/21/17 11:33:10 AM
#47   News coming! sorkin 09/14/17 06:06:26 PM
#46   Will collapse soon Stay tuned for info sorkin 09/12/17 11:51:50 AM
#45   Don't buy this "scam" sorkin 09/12/17 11:41:29 AM
#44   Gag order: Why company doesn't want you to know sorkin 09/12/17 05:39:01 AM
#43   Anyone had the chance to call or email sorkin 09/11/17 12:48:32 PM
#42   What is the real value $20, $15 or $10? sorkin 09/11/17 12:00:25 PM
#41   SA article pumped ADMS: https://www.google.com/amp/s/seekingalpha.com/amp/artic sorkin 09/09/17 01:18:39 PM
#40   https://www.allergan.com/Products/Patents List includes Namenda patent informat sorkin 09/09/17 01:09:45 PM
#39   Strange language use in PR: Adamas is eligible to sorkin 09/09/17 01:05:58 PM
#38   Additional contracts for UCB Pharma: Isabelle.Ghellynck@ucb.com Tel# +32 2 559 sorkin 09/09/17 12:56:43 PM
#37   VIMPAT manufactured by UCB Pharma Inc. Contact UCB Pharma sorkin 09/09/17 12:54:14 PM
#36   What smells like a scam is a SCAM! sorkin 09/09/17 12:48:37 PM
#35   VYGR Parkinson's drug! sorkin 09/06/17 08:42:33 AM
#34   FDA approved "Austedo" for tardive dyskinesia. Beneficiary TEVA sorkin 08/30/17 06:08:45 PM
#33   Secondaries $15 sorkin 08/30/17 03:42:05 PM
#32   Someone pulled the trigger! sorkin 08/29/17 01:48:57 PM
#31   Not a bull on this. Good for those who sorkin 08/29/17 11:58:06 AM
#30   This is a reformulation extended release version that Vonroe 08/27/17 06:14:10 PM
#29   Before getting your hopes up you should google sorkin 08/26/17 01:27:30 PM
#28   "Gocovri" is age old generic medicine "Amantadine " sorkin 08/26/17 01:14:45 PM
PostSubject
© 2018 InvestorsHub.com, Inc.